Effect of the anti‐factor Xa and anti‐factor IIa activities of low‐molecular‐weight heparins upon the phases of thrombin generation
- 1 March 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (5), 955-962
- https://doi.org/10.1111/j.1538-7836.2007.02477.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Generic Low-Molecular-Weight Heparins: Some Practical ConsiderationsSeminars in Thrombosis and Hemostasis, 2004
- Efficacy and safety of bemiparin compared with enoxaparin in the prevention of venous thromboembolism after total knee arthroplasty: a randomized, double-blind clinical trialJournal of Thrombosis and Haemostasis, 2003
- Pharmacology of second generation low molecular weight heparinsPathophysiology of Haemostasis and Thrombosis, 2002
- Low Molecular Weight Heparin for the Prevention of Deep Venous Thrombosis: A Suitable Monitoring in Elderly Patients?Pathophysiology of Haemostasis and Thrombosis, 2002
- Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgeryBritish Journal of Haematology, 1999
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Prothrombin conversion under flow conditions by prothrombinase assembled on adherent plateletsBlood Coagulation & Fibrinolysis, 1997
- Inhibition of thrombin generation by heparin and LMW heparinsBlood Coagulation & Fibrinolysis, 1996
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- A Simple Method of Studying the Generation of Thrombin in Recalcified Plasma: Application in the Investigation of HaemophiliaJournal of Clinical Pathology, 1953